We are live on ! Find out more
HRCM

Hood River Capital Management Portfolio holdings

AUM $9.98B
1-Year Est. Return 145.42%
This Fund
S&P 500
This Quarter Est. Return
+19.57%
1 Year Est. Return
+145.42%
3 Year Est. Return
+584.57%
5 Year Est. Return
+927.1%
10 Year Est. Return
+12,185.37%
AUM
$2.3B
AUM Growth
+$73M
Cap. Flow
-$222M
Cap. Flow %
-9.62%
Top 10 Hldgs %
28.6%
Holding
116
New
15
Increased
26
Reduced
54
Closed
13

Sector Composition

Rank Sector Weight
1 Healthcare 25.72%
2 Technology 23.11%
3 Industrials 16.99%
4 Consumer Discretionary 12.53%
5 Financials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HQY icon
51
HealthEquity
HQY
$8.83B
$17.3M 0.75%
+335,970
New +$18.5M
MGNX icon
52
MacroGenics
MGNX
$249M
$17.1M 0.74%
678,178
-70,740
-9% -$1.93M
ARWR icon
53
Arrowhead Research
ARWR
$12.6B
$16.6M 0.72%
385,259
-38,869
-9% -$1.68M
TXRH icon
54
Texas Roadhouse
TXRH
$13.8B
$16.5M 0.72%
271,514
-156,557
-37% -$9.17M
IOVA icon
55
Iovance Biotherapeutics
IOVA
$2.94B
$16.4M 0.71%
496,865
-50,447
-9% -$1.55M
TWOU
56
DELISTED
2U Inc
TWOU
$15.7M 0.68%
+15,412
New +$18.3M
LRN icon
57
Stride
LRN
$3.29B
$15.5M 0.67%
589,985
-561,700
-49% -$21.7M
ESTC icon
58
Elastic
ESTC
$7.94B
$14.8M 0.64%
137,178
+13,961
+11% +$1.37M
TSC
59
DELISTED
TriState Capital Holdings, Inc.
TSC
$14.7M 0.64%
1,111,273
+142,914
+15% +$2M
XLRN
60
DELISTED
Acceleron Pharma
XLRN
$14.6M 0.64%
129,986
-12,951
-9% -$1.29M
EPAY
61
DELISTED
Bottomline Technologies Inc
EPAY
$14.3M 0.62%
338,869
-143,906
-30% -$6.83M
TREX icon
62
Trex
TREX
$5.07B
$14.2M 0.62%
198,564
-20,146
-9% -$1.39M
CNMD icon
63
CONMED
CNMD
$1.48B
$14.1M 0.61%
179,515
+11,904
+7% +$971K
AXON
64
Axon Enterprise
AXON
$51.7B
$13.7M 0.6%
151,249
-124,523
-45% -$10.8M
KNX icon
65
Knight Transportation
KNX
$11.1B
$13.7M 0.6%
336,796
-33,804
-9% -$1.48M
CERS icon
66
Cerus
CERS
$518M
$13.7M 0.6%
2,189,625
+206,785
+10% +$1.37M
LASR icon
67
nLIGHT
LASR
$2.84B
$13.5M 0.58%
+573,097
New +$13.2M
KPTI icon
68
Karyopharm Therapeutics
KPTI
$47.4M
$13.4M 0.58%
61,051
-6,107
-9% -$1.49M
BHVN
69
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$13.4M 0.58%
205,620
-20,662
-9% -$1.35M
BAND
70
Bandwidth Inc
BAND
$1.66B
$13.3M 0.58%
76,429
-462,356
-86% -$68.5M
AXNX
71
DELISTED
Axonics, Inc. Common Stock
AXNX
$13.2M 0.57%
+258,425
New +$10.8M
DOOR
72
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$13M 0.57%
132,298
-5,117
-4% -$454K
DCPH
73
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$12.9M 0.56%
251,381
-5,650
-2% -$277K
ANGI icon
74
Angi Inc
ANGI
$183M
$12.3M 0.53%
+110,884
New +$15.3M
ZNGA
75
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$12.2M 0.53%
1,335,567
-1,317,554
-50% -$12.3M

Similar funds

Hood River Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Hood River Capital Management held 116 positions worth $2.3B, up 3.3% from $2.23B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Hood River Capital Management withdrew a net $222M in Q3 2020, closing 13 positions and reducing 54 holdings. Its most notable exit was Edgio, Inc. Common Stock, an estimated $33M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Technology and Industrials.

Against the trend, Hood River Capital Management opened a new position in Luminar Technologies worth $21.7M.

  • Hood River Capital Management's largest Q3 2020 buy was Luminar Technologies: 126,762 shares worth $21.7M.
  • Hood River Capital Management added most to Sunnova Energy in Q3 2020, an estimated $28.4M increase.
  • Hood River Capital Management's biggest Q3 2020 reduction was Plug Power, cutting an estimated $70.6M.
  • Hood River Capital Management fully exited Edgio, Inc. Common Stock in Q3 2020, selling an estimated $33M.
  • Hood River Capital Management's ten largest holdings make up 29% of its $2.3B portfolio in Q3 2020.
  • Hood River Capital Management opened 15 new positions and closed 13 in Q3 2020.
  • Hood River Capital Management's portfolio value rose 3.3% quarter-over-quarter to $2.3B.

Based on Hood River Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.